News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
256
Sources here
21
Companies here
6
Search results Stored financial headlines

Active search

256 matching headlines

Ticker or company: OMNMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Omnicom targets 4.5%-5% 2026 organic growth while advancing $900M synergies and completing $5B buyback by Q1 2027

Earnings Call Insights: Omnicom Group Inc. (OMC) Q2 2026 MANAGEMENT VIEW * "Starting with revenue from Core Operations... we achieved organic growth of 6.1% in the second quarter" and "Ongoing or Core Operations adjusted EBITA growth was 20.4%" with "EBITA margin" up "almost 200 …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell (OMCL) Could Be 30% Undervalued If Its OmniSphere Shift Pays Off

Omnicell (OMCL) is attracting attention due to recent share price movements and its strategic shift towards the cloud-native OmniSphere platform, which aims to simplify medication management and boost recurring SaaS-based revenues. While a popular narrative suggests the company is 29.8% undervalued with a fair …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Omnicom tops Q2 2026 estimates, raises outlook

Omnicom Group reported strong second-quarter 2026 results, exceeding Wall Street expectations with adjusted earnings of $2.65 per share and $6.6 billion in revenue. The company benefited from the Interpublic Group acquisition and cost-reduction synergies, leading to a 6.1% organic revenue rise in core operations …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom (OMC) Tops Q2 Earnings and Revenue Estimates

Omnicom (OMC) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $2.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

O1MC34 main company OMC main company
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5% O1MC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group (NYSE:OMC) Beats Q2 CY2026 Sales Expectations But Stock Drops

Omnicom Group reported Q2 CY2026 results, exceeding Wall Street's revenue expectations with sales up 63.4% year-on-year to $6.56 billion. However, despite beating revenue forecasts and maintaining a strong adjusted EPS, its stock dropped 6.5% to $80.60 immediately after the announcement, indicating the market was …

O1MC34 main company OMC main company
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5% O1MC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom: Q2 Earnings Snapshot

The provided content is a very short snippet related to Omnicom and its Q2 earnings, but it lacks any actual article text or financial information. It seems to be an incomplete or placeholder content.

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom falls 2% despite beating second quarter estimates

Omnicom Group Inc. (NYSE:OMC) exceeded analyst expectations for its second-quarter results, with adjusted EPS of $2.65 and revenue of $6.6 billion. Despite this strong performance and a 4.7% gain during the regular session, the company's shares declined 2% in after-hours trading. The growth was …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (OMC) Omnicom Group Inc. Reports Q2 Revenue $6.56B, vs. FactSet Est of $6.44B

Omnicom Group Inc. announced its Q2 revenue of $6.56 billion, surpassing the FactSet estimate of $6.44 billion. This financial update indicates a stronger-than-expected performance for the advertising and marketing giant in the second quarter. The company's results were published on July 28, 2026.

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom's Core Revenue Reaches $6.0B With 6.1% Organic Growth

Omnicom (NYSE: OMC) reported a strong second quarter in 2026, with core operations revenue hitting $6.0 billion, driven by a 6.1% organic growth and a 1.1% foreign currency benefit. The company's Adjusted EBITA rose to $1.07 billion, pushing the margin to 17.8%, mainly due …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Reports Second Quarter 2026 Results

Omnicom (OMC) has announced strong second-quarter 2026 results, with revenue in its Core Operations growing 6.1% organically to $6.0 billion and a notable expansion in Non-GAAP Adjusted EBITA margin to 17.8%. The company reported diluted earnings per share of $2.08, or $2.65 non-GAAP adjusted, …

O1MC34 main company OMC main company
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5% O1MC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Omnicom Group (OMC) Stock Is Up Today

Omnicom Group (OMC) stock is up 4.7% today, likely due to investor anticipation ahead of its Q2 2026 earnings release. Optimism is also fueled by higher-than-expected cost synergies from its Interpublic combination and a significant share repurchase program. The article also provides details on …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (OMC) Omnicom Group Inc. Posts Q2 Adjusted EPS $2.65 per Share, vs. FactSet Est of $2.67

Omnicom Group Inc. (OMC) reported its Q2 adjusted EPS at $2.65 per share, which fell slightly short of the FactSet estimate of $2.67. The company's Q2 revenue was $6.56 billion, surpassing FactSet's estimate of $6.44 billion. The earnings flash highlights the company's financial performance …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom set to report earnings as mega-merger execution scrutinized

Omnicom Group Inc. is reporting second-quarter earnings, with investors keenly watching its execution of the Interpublic acquisition, particularly concerning integration progress, synergy targets, and client retention. Analysts anticipate significant year-over-year growth in EPS and revenue, largely driven by the acquisition. The focus will also …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group stock hits 52-week high at 87.17 USD By Investing.com

Omnicom Group's stock reached a new 52-week high of $87.17, currently trading at $87.18 with a market capitalization of $24.79 billion. InvestingPro analysis suggests the stock is undervalued, offering a 3.88% dividend yield and having maintained dividend payments for 56 consecutive years. This milestone …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enterprise value to EBIT forward of OmniAb, Inc. – NASDAQ:OABI

This article focuses on the enterprise value to EBIT forward for OmniAb, Inc. (NASDAQ:OABI). It indicates that financial data for this metric is provided by FactSet Research Systems Inc. and market data by ICE Data Services.

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(OMC) and the Role of Price-Sensitive Allocations

This article provides an in-depth analysis of Omnicom Group Inc. (NYSE: OMC) focusing on price-sensitive allocations, neutral sentiment, and potential trading strategies. It highlights an exceptional risk-reward short setup and offers AI-generated signals and institutional trading strategies for various risk profiles. The analysis suggests …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OMC Looks 12.9% Undervalued on GF Value™ Heading into Q2 Earnings

Omnicom Group Inc (NYSE: OMC) is preparing to announce its second-quarter earnings, with analysts forecasting significant increases in EPS and revenue. GuruFocus' GF Value™ suggests the stock is modestly undervalued by 12.9%, despite a high trailing P/E ratio, while its GF Score™ of 83 …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Somnigroup Announces Refinancing of Credit Facilities

Somnigroup International Inc. announced the successful refinancing of its $2.9 billion senior secured credit facilities, including a $1.7 billion revolver and a $1.2 billion term loan A. This amendment lowers the company's cost of capital, extends debt maturities, and enhances financial flexibility. The transaction …

SGI main company
Sharemaestro market context Price below Trend Line 52 weeks -20.7% SGI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone

Veraxa Biotech has advanced its bispecific antibody-drug conjugate (ADC) program, VXA-222, into the next development phase after OmniAb completed its antibody discovery work. This collaboration utilizes OmniAb's transgenic antibody discovery platform and Veraxa’s proprietary ADC linker and conjugation technology to create a dual-antigen "AND-gate" …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

VERAXA Biotech (NASDAQ: VRXA) has advanced its bispecific antibody-drug conjugate (bsADC) program, VXA-222, reaching a key technical milestone in its collaboration with OmniAb (NASDAQ: OABI). OmniAb completed its discovery work, moving the program to its next phase. VXA-222 is designed to target two tumor …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group Inc (OMC) Balance Sheet

This article provides a detailed balance sheet for Omnicom Group Inc (OMC), outlining quarterly and annual financial data across various asset, liability, and equity categories. It includes historical data dating back several years, showing trends in cash, receivables, total assets, total liabilities, and shareholders' …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How marketers can tackle a new creative paradigm with connected content

Marketers are facing a new creative paradigm called "connected content" due to media fragmentation, second screening, and AI. This model, proposed by Omnicom Media Intelligence, aims to integrate various channels like media, commerce, and creator marketing into content creation for more effective campaigns. It …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OABI|OmniAb Inc|Price:2.030|

OmniAb Inc. (OABI) licenses discovery research technology to pharmaceutical and biotech companies, leveraging its OmniAb platform to identify optimal antibodies for drug development. The company utilizes engineered transgenic animals like OmniRat and OmniChicken to generate human sequence antibodies. OmniAb's top five shareholders include Mr. …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veraxa advances cancer therapy program with OmniAb

Veraxa Biotech AG announced that its bispecific antibody-drug conjugate program, VXA-222, advanced to the next development phase after completing discovery work with OmniAb, Inc. The program targets solid tumors using AND-gate logic, combining OmniAb's antibody discovery technologies with Veraxa's linker technology. Veraxa holds exclusive …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

VERAXA Biotech announced the advancement of its bispecific ADC (bsADC) program VXA-222, developed in collaboration with OmniAb. This program, which uses an "AND-gate" logic to target solid tumors, has moved into its next phase following the successful completion of OmniAb's discovery work. VERAXA will …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group Inc Revenue Breakdown – MIL:1OMC

Omnicom Group Inc. (MIL:1OMC) generated total revenue of €14.71 billion last year. Its top-performing segment, Media & Advertising, contributed €8.53 billion, an increase from €8.18 billion in the previous year. The United States was the largest geographical contributor, accounting for €7.75 billion, slightly down …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for OmniAb Inc (OABI) across its business segments for various fiscal quarters and years. It highlights that the company's main revenue streams are service revenue, license and milestone revenue, royalty revenue, and xPloration revenue. The data is …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group (OMC) Q2 Earnings: What To Expect

Omnicom Group (OMC) Q2 Earnings: What To Expect Global advertising giant Omnicom Group (NYSE:OMC) will be announcing earnings results this Tuesday after market hours. Here's what investors should know. Omnicom Group beat analysts' revenue expectations last quarter, reporting revenues of $6.24 billion, up 69.2% …

O1MC34 main company OMC main company
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5% O1MC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OmniAb Inc (OABI) Balance Sheet

This article provides the quarterly and annual balance sheets for OmniAb Inc (OABI), allowing users to assess the company's financial health, fundamentals, and key financial ratios. It details assets, liabilities, and shareholders' equity over recent fiscal quarters and years, along with frequently asked questions …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group stock trades steadily as revenue growth and margins support valuation

Omnicom Group stock demonstrates stable performance due to consistent revenue growth, strong margins, and shareholder-friendly capital allocation. The company, a major global advertising and marketing services provider, has shown year-over-year increases in revenue and net income, alongside solid EPS growth. This financial health supports …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OABI Income Statement Analysis - OmniAb Inc

This article provides a detailed quarterly and annual income statement analysis for OmniAb Inc (OABI). It outlines key financial metrics, including total revenue, operating expenses, net income, and earnings per share, along with year-over-year comparisons. The report also addresses frequently asked questions about interpreting …

OABI main company
Sharemaestro market context Trend signal active 52 weeks +82.7% · Next-week setup negative 32.6% OABI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicom Group Inc (OMC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and stock split information for Omnicom Group Inc (OMC). It details dividend dates, including record, payment, and ex-dividend dates, along with the gross cash dividend amounts. The data spans from late 2024 to late 2026, …

OMC main company
Sharemaestro market context Trend signal active 52 weeks +14.4% OMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context